- $836.01m
- $733.52m
- $500.89m
- 96
- 59
- 92
- 96
Annual balance sheet for Proto Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 162 | 77.5 | 80.1 | 103 | 103 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 58.4 | 81.4 | 80.3 | 75.1 | 69.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 242 | 183 | 187 | 201 | 195 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 295 | 288 | 279 | 259 | 231 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 744 | 929 | 802 | 772 | 744 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 50.3 | 54.9 | 71.6 | 49.7 | 53.3 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 99.8 | 100 | 105 | 77.1 | 73.4 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 644 | 828 | 698 | 695 | 670 |
Total Liabilities & Shareholders' Equity | 744 | 929 | 802 | 772 | 744 |
Total Common Shares Outstanding |